My ePortfolio Register   

Abstract | Full HTML Article | PDF | Spanish ecancer 11 740 /

Case Report

Soft-tissue sarcomas in the head and neck: 25 years of experience

Sarcomas are infrequent and heterogeneous tumours. They represent 1–2% of all malignant neoplasms in adults and between 4% and 10% of head and neck cancers.

Methods: The research was retrospective, descriptive, and cross-sectional.

Results: A study population of 62 patients with a mean age of 44 years was obtained; the most frequent location was the soft tissues of the neck (25.3%) and the mean tumour size was 7.1 cm; the most frequent diagnosis was undifferentiated pleomorphic sarcoma (25.5%) and the majority were stage III (41.4%). The lowest survival rates were associated with T2a and T2b tumours (p = 0.014), the presence of lymph node metastasis (p = 0.001), advanced stages (p = 0.003), and invasion of bone, blood vessels and/or nerves (p = 0.008).

Conclusions: Late diagnosis is the main factor associated with decreased survival in patients with head and neck sarcomas.

Keywords: soft-tissue sarcoma, head and neck neoplasms, head, neck


Head & neck

Loading Article Metrics ... Please wait

Related articles

Research: Diagnostic validity of fine-needle capillary cytology in palpable tumours at the Oncology Institute of Peru

Abstract | Full Article | PDF | Spanish Published: 01 Feb 2018 /

Case Report: Metastasizing pleomorphic adenoma of the parotid gland

Abstract | Full Article | PDF Published: 15 Aug 2017 /

Research: Clinical, epidemiological, and therapeutic profile of patients with a retinoblastoma diagnosis experience in the Costa Rica National Children’s Hospital Oncology Unit from January 2009 to December 2015

Abstract | Full Article | PDF Published: 24 Jul 2017 /

Research: Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma

Abstract | Full Article | PDF Published: 13 Jun 2017 /

Conference Report: Conference report on the Indo Global Summit on Head and Neck Oncology (IGSHNO 2017-BMCON-IV), 24–26 February 2017, Jaipur, India

Abstract | Full Article | PDF Published: 31 May 2017 /

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence